Skip to main content

Table 1 Characteristics, therapies and outcomes of children with acute respiratory failure (n = 29,362)

From: Early predictors of unfavorable outcomes in pediatric acute respiratory failure

Variables

n

(%)

Age, years, median (IQR)

1.2

(0.3–3.7)

 < 1 year

13,057

(44.5)

 1–5 years

11,399

(38.8)

 6–19 years

4906

(16.7)

Male

16,563

(56.4)

Underlying conditions, any

8446

(28.8)

 Neurological/neuromuscular

3926

(13.4)

 Cardiovascular

2194

(7.5)

 Respiratory

1753

(6.0)

 Congenital/genetic

1880

(6.4)

 Premature/neonatal

395

(1.3)

 Hematological/immunological/malignancy/transplantation

715

(2.4)

Diagnostic category

 Pneumonia

17,201

(58.6)

 Bronchiolitis

8506

(29.0)

 Asthma

3260

(11.1)

 Others

395

(1.3)

Pathogen

  

 Viral

12,135

(41.3)

 Bacterial

3826

(13.0)

 Aspiration

785

(2.7)

 COVID-19

48

(0.2)

 No detection

12,568

(42.8)

Organ dysfunction on admission

  

 Impaired consciousness

  

  No-mild

26,409

(89.9)

  Moderate

859

(2.9)

  Severe

2094

(7.1)

 Acute liver failure

12

(0.0)

 Thrombocytopenia/coagulopathy

276

(0.9)

Transported from other hospitals

5496

(18.7)

Admitted to accredited ICUs

8521

(29.0)

Hospital volume, cases, median (IQR)

105

(51–319)

Length of ventilatory support, days, median (IQR)

5

(3–8)

Length of invasive ventilation, days, median (IQR) a

6

(3–9)

Length of hospital stay, days, median (IQR)

9

(7–14)

In-hospital death

669

(2.3)

Discharged with comorbidities

1994

(6.8)

  1. Data are presented as n (%) unless otherwise indicated
  2. COVID-19, coronavirus disease. 2019; IQR, interquartile range; ICU, intensive care unit
  3. aLength of invasive ventilation in 20,365 children mechanically ventilated within the first three days of hospitalization